Data Up to Date as of:
On This Page:
In 2015, 22.9% of females aged 18 years and older with a family history of breast and/or ovarian cancer had discussed the possibility of getting a genetic test for cancer risk.
Background
Genetic testing looks for specific inherited changes in a person’s DNA (or genetic mutations) that may increase a person’s chance of developing a disease such as cancer. Genetic testing should be considered if personal or family history suggests an inherited cancer risk condition. The test results can help guide a person’s future medical care.
A genetic counselor is a health professional who has special training in medical genetics and counseling. Any person who is considering genetic testing should speak with a genetic counselor before deciding whether to be tested. Genetic counselors can also discuss the risks, benefits, and limitations of genetic testing for individuals to help them understand their situation.
Measure
Percentage of females aged 18 years and older with a family history of breast and/or ovarian cancer who had discussed the possibility of getting a genetic test for cancer risk with a doctor or other health professional, 2005-2015.
Percentage of adults aged 18 years and older with a personal history of colorectal cancer who had discussed the possibility of getting a genetic test for cancer risk with a doctor or other health professional, by sex, 2005-2015.
Percentage of adults aged 18 years and older with a personal history of colorectal cancer who had a genetic test for cancer risk, by sex, 2005-2015.
Healthy People 2030 Target
- (Developmental Objective) Increase the proportion of women with a family history of breast and/or ovarian cancer who receive genetic counseling.
- (Research Objective) Increase the proportion of persons with newly diagnosed colorectal cancer who receive genetic testing to identify Lynch syndrome or familial colorectal cancer syndromes.
Healthy People 2030 is a set of goals set forth by the Department of Health and Human Services.
Note: Healthy People 2030 Developmental and Research Objectives do not have targets, so that is why there is no target line on the Detailed Trend Graphs. Learn more about different types of Healthy People Objectives.
Data Source
Centers for Disease Control and Prevention, National Center for Health Statistics. National Health Interview Survey NCI and CDC co-sponsored Cancer Control Supplement, 2005-2015.
Trends and Most Recent Estimates
Breast and Ovarian Cancer
| Overview Graph | Detailed Trend Graphs | Most Recent Estimates (2015) | |
|---|---|---|---|
| Percent of females | 95% Confidence Interval | ||
|
Discussed the Possibility of a Genetic Test for Cancer Risk
|
22.9 | 12.8 - 37.6 |
| ¹ Analysis includes females who met the USPSTF guidelines based on family history of breast and ovarian cancer. | |||
Colorectal Cancer
Genetic Counseling
| Overview Graph | Detailed Trend Graphs | Most Recent Estimates (2015) | |
|---|---|---|---|
| Percent of adults with personal history of colorectal cancer | 95% Confidence Interval | ||
|
Both Sexes
|
10.3 | 6.0 - 17.1 |
Male
|
7.6 | 3.3 - 16.6 | |
Female
|
12.6 | 6.2 - 23.9 | |
Genetic Testing
| Overview Graph | Detailed Trend Graphs | Most Recent Estimates (2015) | |
|---|---|---|---|
| Percent of adults with personal history of colorectal cancer | 95% Confidence Interval | ||
|
Both Sexes
|
6.1 | 2.9 - 12.3 |
Male
|
2.0 | 0.7 - 5.4 | |
Female
|
9.8 | 4.3 - 21.1 | |
Additional Information on Genetic Testing
- The Genetics of Cancer. National Cancer Institute.
- Genetic Testing for Hereditary Cancer Syndromes. National Cancer Institute.
- Genetic Testing for Cancer Risk. American Society of Clinical Oncology.
- Cancer Genetics Overview (PDQ®)–Health Professional Version. National Cancer Institute.
- Cancer Genetics Risk Assessment and Counseling (PDQ®)–Health Professional Version. National Cancer Institute.
- Utilization and outcomes of BRCA genetic testing and counseling in a nation commercially insured population: the ABOUT Study. Armstrong J, Toscano M, Kotchko N, et al. JAMA Oncol 2015;1(9):1251-60.
- Panel testing is not a panacea. Axilbund JE. J Clin Oncol. 2016;34(13):1433-5.
- How and When to Consider Genetic Testing for Colon Cancer? Ballester V, Cruz-Correa M. Gastroenterology 2018; 155(4): 955-59.
- The genetic basis for cancer treatment decisions. Dancey JE, Bedard PL, Onetto N, and Hudson TJ. Cell 2012:148(3):409-20.
- Genetic/familial high-risk assessment: breast and ovarian, version 2.2015. Daly MB, Pilarski R, Axilbund JE, et al. J Natl Compr Canc Netw 2016; 14(12): 153-62.
- Clinical actionability of multigene panel testing for hereditary breast and ovarian cancer risk assessment. Desmond A, Jurian AW, Gabree M, et al. JAMA Oncol 2015; 1(7):943-51.
- What’s new in genetic testing for cancer susceptibility?. Plichta JK, Griffin M, Thakuria J, and Hughes KS. Oncology 2016; 30(9): 787-99.
- Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer. US Preventive Services Task Force, Owens DK, Davidson KW, et al. JAMA 2019; 322(7): 652-65.